J Gen Virol Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosmorduc, O.
Right arrow Articles by Kremsdorf, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosmorduc, O.
Right arrow Articles by Kremsdorf, D.
Agricola
Right arrow Articles by Rosmorduc, O.
Right arrow Articles by Kremsdorf, D.

Journal of General Virology, Vol 80, 1253-1262, Copyright © 1999 by Society for General Microbiology

ARTICLES

Inhibition of interferon-inducible MxA protein expression by hepatitis B virus capsid protein

O Rosmorduc, H Sirma, P Soussan, E Gordien, P Lebon, M Horisberger, C Brechot and D Kremsdorf
INSERM U370, CHU Necker, 156 rue de Vaugirard, 75015 Paris, France

Chronic hepatitis B treatment has been significantly improved by interferon (IFN) treatment. However, some studies have suggested that hepatitis B virus (HBV) might have a direct effect on the resistance to IFN. Defective particles, generated by spliced HBV RNA and associated with chronic hepatitis B, have been previously characterized; expression of these particles leads to cytoplasmic accumulation of the capsid protein. The aim of this study was to investigate the role of these defective genomes in IFN resistance. The global antiviral activity of IFN was studied by virus yield reduction assays, the expression of three IFN-induced antiviral proteins was analysed by Western blotting and confocal microscopy, and the regulation of MxA gene expression was studied by Northern blotting and the luciferase assay, in Huh7 cells transfected with a complete or the defective HBV genome. Results showed that the expression of the defective genome reduces the antiviral activity of IFN and that this modulation involves a selective inhibition of MxA protein induction by the HBV capsid protein. Our results also show the trans-suppressive effect of the HBV capsid on the MxA promoter, which might participate in this phenomenon. In conclusion, this study shows a direct interplay between the IFN-sensitive pathway and the capsid protein and might implicate this defective HBV genome in virus persistence.


This article has been cited by other articles:


Home page
 J. Gen. Virol.Home page
M. Fernandez, J. A. Quiroga, and V. Carreno
Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins
J. Gen. Virol., August 1, 2003; 84(8): 2073 - 2082.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
E. Gordien, O. Rosmorduc, C. Peltekian, F. Garreau, C. Bréchot, and D. Kremsdorf
Inhibition of Hepatitis B Virus Replication by the Interferon-Inducible MxA Protein
J. Virol., March 15, 2001; 75(6): 2684 - 2691.
[Abstract] [Full Text]

Home page
 J. Gen. Virol.Home page
S. Goodbourn, L. Didcock, and R. E. Randall
Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures
J. Gen. Virol., October 1, 2000; 81(10): 2341 - 2364.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1999 by the Society for General Microbiology.